Inke S.A: APIs manufacturing plant.
01 1INKE, S.A.
02 1PCAS FINLAND OY
03 2Anonima Materie Sintetiche and Affini (AMSA) Spa
04 2AstraZeneca AB
05 2AstraZeneca Pharmaceuticals LP
06 1Cerbios-Pharma SA
07 1Fagron Inc
08 1HARMAN FINOCHEM LIMITED
09 1Hainan Poly Pharm. Co., Ltd.
10 1Harman Finochem Limited
11 1Hikma Pharmaceuticals
12 1LETCO MEDICAL, LLC
13 1Medisca Inc.
14 1Olon SpA
15 1Professional Compounding Centers of America dba PCCA
16 1Spectrum Laboratory Products, Inc.
17 1Suven Pharmaceuticals Limited
18 1Suven Pharmaceuticals Ltd
19 1Viyash Life Sciences Private Limited
01 3GLYCOPYRROLATE
02 1GLYCOPYRROLATE TOSYLATE
03 1Glycopirronium Bromide
04 11Glycopyrrolate
05 1Glycopyrrolate Tosylate
06 1Glycopyrronium Tosylate Monohydrate
07 4Micronized Glycopyrronium Bromide
01 1China
02 1France
03 5India
04 3Italy
05 1Netherlands
06 1Spain
07 1Switzerland
08 3U.S.A
09 6United Kingdom
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0018
Start Marketing Date : 2017-07-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 51014-7146
Start Marketing Date : 2009-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17373-1035
Start Marketing Date : 2015-02-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17373-1036
Start Marketing Date : 2017-01-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0310-0561
Start Marketing Date : 2022-09-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (68g/68g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0310-5600
Start Marketing Date : 2022-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (68g/68g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17228-4610
Start Marketing Date : 2022-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1188g/1188g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17228-5600
Start Marketing Date : 2022-10-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1188g/1188g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14335-250
Start Marketing Date : 2021-12-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0545
Start Marketing Date : 2017-03-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
15
PharmaCompass offers a list of Glycopyrronium Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glycopyrronium Bromide manufacturer or Glycopyrronium Bromide supplier.
PharmaCompass also assists you with knowing the Glycopyrronium Bromide API Price utilized in the formulation of products. Glycopyrronium Bromide API Price is not always fixed or binding as the Glycopyrronium Bromide Price is obtained through a variety of data sources. The Glycopyrronium Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bromuro de glicopirronio manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromuro de glicopirronio, including repackagers and relabelers. The FDA regulates Bromuro de glicopirronio manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromuro de glicopirronio API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bromuro de glicopirronio manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bromuro de glicopirronio supplier is an individual or a company that provides Bromuro de glicopirronio active pharmaceutical ingredient (API) or Bromuro de glicopirronio finished formulations upon request. The Bromuro de glicopirronio suppliers may include Bromuro de glicopirronio API manufacturers, exporters, distributors and traders.
click here to find a list of Bromuro de glicopirronio suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bromuro de glicopirronio as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bromuro de glicopirronio API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bromuro de glicopirronio as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bromuro de glicopirronio and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bromuro de glicopirronio NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bromuro de glicopirronio suppliers with NDC on PharmaCompass.
We have 16 companies offering Bromuro de glicopirronio
Get in contact with the supplier of your choice:
